Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 4
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Variant allele frequency: a decision-making tool in precision oncology?
Boscolo Bielo L, Trapani D, Repetto M, Crimini E, Valenza C, Belli C, Criscitiello C, Marra A, Subbiah V, Curigliano G. Boscolo Bielo L, et al. Trends Cancer. 2023 Dec;9(12):1058-1068. doi: 10.1016/j.trecan.2023.08.011. Epub 2023 Sep 12. Trends Cancer. 2023. PMID: 37704501 Review.
Future potential targets of antibody-drug conjugates in breast cancer.
Corti C, Boscolo Bielo L, Schianca AC, Salimbeni BT, Criscitiello C, Curigliano G. Corti C, et al. Among authors: boscolo bielo l. Breast. 2023 Jun;69:312-322. doi: 10.1016/j.breast.2023.03.007. Epub 2023 Mar 24. Breast. 2023. PMID: 36996620 Free PMC article. Review.
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer.
Cantini L, Trapani D, Guidi L, Boscolo Bielo L, Scafetta R, Koziej M, Vidal L, Saini KS, Curigliano G. Cantini L, et al. Among authors: boscolo bielo l. Cancer Treat Rev. 2024 Feb;123:102669. doi: 10.1016/j.ctrv.2023.102669. Epub 2023 Dec 10. Cancer Treat Rev. 2024. PMID: 38141462 Review.
Treatment optimization in early triple negative breast cancer.
Kotteas E, Bielo LB, Valenza C, Santoro C, Koukoutzeli C, Trapani D, Curigliano G. Kotteas E, et al. Among authors: bielo lb. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(10):1107-1116. doi: 10.1080/14737140.2023.2268840. Epub 2023 Oct 26. Expert Rev Anticancer Ther. 2023. PMID: 37873652 Review.
Postneoadjuvant treatment for triple-negative breast cancer.
Trapani D, Ferraro E, Giugliano F, Boscolo Bielo L, Curigliano G, Burstein HJ. Trapani D, et al. Among authors: boscolo bielo l. Curr Opin Oncol. 2022 Nov 1;34(6):623-634. doi: 10.1097/CCO.0000000000000893. Epub 2022 Aug 19. Curr Opin Oncol. 2022. PMID: 35993306 Review.
Antibody-Drug Conjugates in Breast Cancer: What Is Beyond HER2?
Nicolò E, Repetto M, Boscolo Bielo L, Tarantino P, Curigliano G. Nicolò E, et al. Among authors: boscolo bielo l. Cancer J. 2022 Nov-Dec 01;28(6):436-445. doi: 10.1097/PPO.0000000000000629. Cancer J. 2022. PMID: 36383906 Review.
20 results